22nd Century Group insider reports RSUs and 51,888-share option
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
22nd Century Group (XXII) director Andrew Arno reported equity awards. On 11/10/2025, he acquired 17,295 shares of common stock for $0, described as restricted stock units that vest 1/3 each on November 10, 2026, 2027, and 2028, subject to continued service. He also received a non‑qualified stock option for 51,888 shares at an exercise price of $1.27, expiring 11/10/2035, vesting 1/3 annually on the grant anniversary.
Following the reported transactions, common stock beneficially owned was 17,481 shares, held directly. The filing also lists an existing option for 553 shares at $46.23, expiring 03/10/2035. Share amounts reflect a 1‑for‑23 stock split effective June 20, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Arno Andrew
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option | 51,888 | $0.00 | -- |
| Grant/Award | Common Stock | 17,295 | $0.00 | -- |
| holding | Non-Qualified Stock Option | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option — 51,888 shares (Direct);
Common Stock — 17,481 shares (Direct)
Footnotes (1)
- The restricted stock units vest 1/3 per year on November 10, 2026, 2027 and 2028, subject to continued service with the Company. The amount shown reflects the number of shares held following the reported transaction, as adjusted for a 1-for-23 stock split effectuated by the issuer on June 20, 2025. Options vest 1/3 per year on the anniversary of the date of grant, subject to continued service with the Company.
FAQ
What did 22nd Century Group (XXII) disclose in this Form 4?
A director, Andrew Arno, reported acquiring 17,295 shares (via RSUs) at $0 on 11/10/2025 and receiving a 51,888-share stock option at $1.27, expiring 11/10/2035.
What is the vesting schedule for the RSUs reported by XXII?
The restricted stock units vest 1/3 per year on November 10, 2026, 2027, and 2028, subject to continued service.
What are the key terms of the newly granted XXII stock option?
Non‑qualified option for 51,888 shares at a $1.27 exercise price, vesting 1/3 annually on the grant anniversary, expiring 11/10/2035.
Were there other XXII options reported in the filing?
Yes. An existing option for 553 shares at a $46.23 exercise price, expiring 03/10/2035, was listed.